Monopar Therapeutics Inc

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

In its most recent quarterly, Monopar Therapeutics Inc had 52.54M in cash and cash equivalents.

Monopar Therapeutics Inc reported 2.89M in total liabilities as of the latest reported quarter, including 2.74M in current liabilities and 154.92K in non-current liabilities.

As of the latest reported quarter, Monopar Therapeutics Inc's total assets were 140.72M, consisting of 140.46M in current assets and 254.92K in non-current assets.

Monopar Therapeutics Inc reported 137.83M in total shareholders' equity as of the latest reported quarter.